Health News Archive - June 14, 2010
SEATTLE, June 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
ANN ARBOR, Mich., June 14 /PRNewswire/ -- The U.S.
WAYNE, N.J. and EMERYVILLE, Calif., June 14 /PRNewswire-FirstCall/ -- Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc.
EMERYVILLE, Calif., June 14 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will host a teleconference and webcast on Monday, June 14, 2010, at 9:00 a.m. Eastern Time (6:00 a.m.
SAN DIEGO, June 14 /PRNewswire-USNewswire/ -- Dr. Carolle Jean-Murat, a San Diego based OB-Gyn surgeon and intuitive healer is returning July 1st to Haiti, the land of her birth, to continue assisting in the humanitarian effort for that devastated country.
LONDON, June 14, 2010 /PRNewswire-FirstCall/ -- - Lending Solution Reduces Costs by as Much as 20 Per Cent and Improves Loan Turnaround Time and Efficiency Misys PLC, a global provider of application software and services for the banking and financial industry, has announced that the National Bank of Abu Dhabi (NBAD) will deploy its commercial lending solution, Misys Loan IQ, for its loan operations. "The solution proposed by Misys will provide the bank with market-leading functionality that addresses each area of the bank's requirements from the Structured Finance Team, Credit Management, Risk Control, Accounting and Compliance and Portfolio Management.
BETHESDA, Md., June 14 /PRNewswire-Asia/ -- Chindex International, Inc. ("Chindex") (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, and Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
BETHESDA, Md., June 14 /PRNewswire-Asia/ -- Chindex International, Inc. (Nasdaq: CHDX), a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the fourth quarter and fiscal year ended March 31, 2010. Financial Highlights: -- Revenue of $171.2 million in the fiscal year 2010 -- Operating income up 76.6% year over year to $14.4 million in the fiscal year 2010 -- Net income up 65% year over year to $8.2 million in the fiscal year 2010, or $0.52 per diluted share, from $5.0 million, or $0.31 per diluted share in the prior year Roberta Lipson, President and CEO of Chindex, commented, "We are pleased with our fiscal year 2010 financial results in which we demonstrated steady growth in Healthcare Services of 8% and increased profitability for the firm as a whole.
SAN DIEGO, June 14 /PRNewswire/ -- aTyr Pharma, Inc. today announced that Catharine E. Johnson, Ph.D. has recently joined the company as its Senior Vice President of Business Development. Dr.
CAMBRIDGE, England, June 14, 2010 /PRNewswire/ -- Executives from Senexis Limited (Cambridge,UK) signed an agreement with O2h (Ahmedabad, India) under which O2h will provide Senexis with chemistry services to support a patent filing on a novel chemical series that have shown potential in pre-clinical models, as disease modifying treatments for Alzheimer's Disease. Dr.